# ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis

> **NCT02126670** · PHASE2 · COMPLETED · sponsor: **Promius Pharma, LLC** · enrollment: 100 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** ACT01
- **DRUG:** Comp01
- **DRUG:** Comp02
- **DRUG:** Comp03
- **DRUG:** Comp04

## Key facts

- **NCT ID:** NCT02126670
- **Lead sponsor:** Promius Pharma, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2014-09
- **Final completion:** 2014-09
- **Target enrollment:** 100 (ACTUAL)
- **Last updated:** 2016-02-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02126670

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02126670, "ACT01 in Combination With Comp01-04 in Patients With Actinic Keratosis". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02126670. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*